Clinical Guides
Mitral Valve Disease
A clinically focused guide to mitral stenosis and regurgitation for Indian clinical learning, integrating rheumatic disease, echocardiographic assessment, medicines, prophylaxis, intervention, pregnancy and access limits without substituting for specialist valve-team decisions.
MedNext Academy | 13 min read
Mitral Valve Disease
A clinically focused guide to mitral stenosis and regurgitation for Indian clinical learning, integrating rheumatic disease, echocardiographic assessment, medicines, prophylaxis, intervention, pregnancy and access limits without substituting for specialist valve-team decisions.
Summary
Mitral valve disease is not one diagnosis. Mitral stenosis obstructs left-atrial emptying, whereas mitral regurgitation permits systolic backflow from the left ventricle into the left atrium. Either lesion may be isolated, mixed with the other, or accompanied by disease of additional valves. Rheumatic commissural fusion remains an important cause of stenosis in India; degenerative calcification, congenital abnormalities and previous intervention form a smaller but clinically distinct group. Regurgitation may be primary, from leaflet, chordal, papillary-muscle or annular pathology, or secondary, when ventricular or atrial remodelling prevents otherwise less abnormal leaflets from coapting.
Symptoms arise from pulmonary venous pressure, reduced forward output, atrial fibrillation, pulmonary hypertension or ventricular dysfunction. Breathlessness, orthopnoea, reduced exercise tolerance, palpitations and embolic events require a structured assessment rather than diagnosis from a murmur alone. Transthoracic echocardiography defines anatomy, haemodynamic severity and chamber response; transoesophageal and other imaging answer selected questions. Management ranges from surveillance and treatment of complications to percutaneous commissurotomy, surgical repair or replacement, and transcatheter edge-to-edge repair in carefully selected regurgitation. Medicines can control congestion, rate, rhythm or thromboembolic risk but do not reverse a fixed mechanical lesion. Acute pulmonary oedema, shock, suspected endocarditis or acute severe regurgitation is an emergency. This draft is educational, reviewed and has been reviewed by the MedNext Clinical Team.
How Common Is It?
The distribution of mitral disease varies sharply by age, geography, living conditions and access to prevention. Rheumatic fever and rheumatic heart disease remain linked to poverty, crowding, barriers to timely treatment of group A streptococcal infection and gaps in long-term secondary prophylaxis. Consequently, rheumatic mitral stenosis may present in younger adults in India than degenerative valve disease does in many higher-income populations. Women are commonly affected by rheumatic stenosis and may first become symptomatic when pregnancy or atrial fibrillation increases haemodynamic demand.
Mitral regurgitation has several populations rather than one useful prevalence figure. Primary degenerative regurgitation rises with age. Secondary ventricular regurgitation accompanies ischaemic or non-ischaemic left-ventricular dysfunction, while atrial secondary regurgitation can accompany longstanding atrial fibrillation and atrial dilatation. Acute regurgitation from papillary-muscle rupture, chordal rupture or endocarditis is uncommon but disproportionately dangerous. Echocardiographic case series from referral centres cannot be treated as national community prevalence because referral bias, inconsistent access and differing diagnostic thresholds alter the denominator.
For an individual patient, symptom burden and cardiac response matter more than a generic percentage. Mild disease may remain stable for years, whereas severe stenosis or regurgitation can progress silently before decompensation. Local services should track aetiology, severity, atrial fibrillation, pregnancy risk, time to intervention and loss to follow-up. This guide deliberately avoids claiming a current all-India prevalence where no single source provides a contemporaneous, representative estimate.
Risk Factors
For rheumatic mitral stenosis, the antecedent pathway is immune-mediated injury after group A streptococcal infection and recurrent rheumatic fever. Overcrowding, delayed access to primary care, missed recognition of rheumatic fever and interrupted benzathine penicillin delivery sustain preventable progression. A history of migratory arthritis, chorea, childhood cardiac illness or prolonged prophylaxis may be absent or forgotten, so lack of recall does not exclude rheumatic disease. Valve morphology, not nationality or age alone, should establish the likely cause. Degenerative mitral stenosis is associated with mitral annular calcification, advanced age, chronic kidney disease and broader calcific disease; its anatomy and procedural options differ from commissural fusion.
Primary mitral regurgitation may result from myxomatous degeneration and prolapse, flail leaflet from chordal rupture, rheumatic restriction, endocarditis, connective-tissue disease, congenital cleft or papillary-muscle injury. Secondary regurgitation reflects ventricular dilatation, regional ischaemic tethering or atrial and annular enlargement. Prior myocardial infarction, cardiomyopathy, hypertension, atrial fibrillation and heart failure therefore change both mechanism and management. Radiation, inflammatory disease and previous valve intervention are additional considerations.
Risk of complications rises with severe haemodynamic disease, left-atrial enlargement, atrial fibrillation, pulmonary hypertension, ventricular dysfunction, prior embolism, pregnancy and delayed follow-up. Dental sepsis and intravascular infection exposures matter for endocarditis prevention, but native mitral disease alone does not automatically create an indication for procedural antibiotic prophylaxis. Record anticoagulant adherence, bleeding risk, renal function, planned pregnancy, access to monitoring and the feasibility of reaching a valve centre before selecting long-term therapy.
Diagnosis
History
Define onset, tempo and functional limitation. Ask about exertional dyspnoea, orthopnoea, paroxysmal nocturnal dyspnoea, fatigue, reduced exercise capacity, palpitations, syncope, haemoptysis, chest discomfort, oedema and embolic symptoms. Sudden breathlessness after myocardial infarction, infection or a chordal event suggests acute regurgitation. Establish childhood rheumatic fever, prior prophylaxis, dental infection, fever, stroke, pregnancy plans, previous echocardiograms and interventions. Document medicines, anticoagulant control, bleeding, renal disease and whether symptoms are limited by pulmonary, anaemic or musculoskeletal disease.
Examination
Assess haemodynamic stability, oxygenation, rhythm, pulse volume, jugular venous pressure, pulmonary congestion, peripheral perfusion and oedema. Auscultation may identify an opening snap and diastolic rumble of stenosis or an apical systolic murmur of regurgitation, but intensity does not reliably grade severity. Look for atrial fibrillation, pulmonary hypertension, right-heart failure and signs of infective endocarditis. In acute severe regurgitation the murmur may be short or unimpressive because pressures equalise rapidly.
Investigations
A twelve-lead ECG, chest radiograph and baseline laboratory tests support assessment but do not define the valve lesion. Transthoracic echocardiography is central: identify mechanism, use a multiparametric severity assessment, measure chamber size and function, and estimate pulmonary pressure. Transoesophageal echocardiography is used when transthoracic views are inadequate, thrombus or endocarditis is suspected, or anatomy must be clarified before intervention. Exercise testing, stress echocardiography, cardiac magnetic resonance, computed tomography and coronary assessment are selective. Discordant symptoms and measurements require expert review, not averaging incompatible numbers.
Differential Diagnosis
Breathlessness in a person with a murmur may arise from heart failure caused by another lesion, coronary disease, cardiomyopathy, chronic lung disease, pulmonary embolism, anaemia, thyroid disease, infection, obesity or deconditioning. Atrial fibrillation can be both consequence and independent driver of symptoms. The clinician must show that the mitral abnormality is sufficiently severe and haemodynamically plausible before attributing all limitation to it. Functional capacity that appears normal only because activity has been reduced should not be mistaken for absence of symptoms.
For mitral stenosis, distinguish rheumatic commissural fusion from degenerative annular calcification, congenital stenosis, left-atrial myxoma, cor triatriatum and high-flow states that elevate transmitral gradients. Tachycardia shortens diastole and can exaggerate gradients; flow, rhythm and heart rate must accompany every interpretation. Aortic regurgitation, tricuspid disease and pulmonary hypertension may alter physical findings. For mitral regurgitation, separate primary structural disease from ventricular or atrial secondary mechanisms because repairability, medical treatment and procedural evidence differ.
Acute severe regurgitation must be differentiated from ventricular septal rupture, acute aortic regurgitation, massive pulmonary embolism and primary respiratory failure. Fever with new regurgitation raises infective endocarditis, but sterile inflammatory or degenerative lesions can mimic vegetations. Eccentric jets may be underestimated by a single colour Doppler image, while physiologic trace regurgitation should not be labelled disease. When clinical and echocardiographic findings conflict, repeat high-quality imaging, review loading conditions and seek valve-imaging expertise before intervention.
Management
Management begins by naming the lesion, mechanism, severity, consequences and patient goals. Mild or moderate stable disease generally requires education, interval clinical and echocardiographic surveillance, oral health, cardiovascular risk management and clear return precautions. Diuretics relieve congestion; rate or rhythm strategies may improve filling and symptoms; anticoagulation prevents selected embolic events. None opens a fused commissure or repairs a flail leaflet. Progressive symptoms, chamber damage, pulmonary hypertension, atrial fibrillation or pregnancy planning should trigger earlier valve-team assessment rather than repeated symptomatic prescribing.
For clinically severe rheumatic stenosis with suitable anatomy, percutaneous mitral commissurotomy is the standard intervention in many patients. Left-atrial thrombus, more than mild regurgitation, extensive calcification, absent commissural fusion or other disease requiring surgery can make it unsuitable. Surgery is used when anatomy, concomitant lesions or failed percutaneous treatment require it. Degenerative calcific stenosis is a separate high-risk problem; both surgical and transcatheter approaches demand expert imaging and individualized assessment.
In severe primary regurgitation, durable surgical repair is preferred when feasible, with timing based on symptoms, ventricular response, atrial or pulmonary consequences and repair likelihood. Transcatheter edge-to-edge repair is an option for selected symptomatic patients who are inoperable or high risk. In ventricular secondary regurgitation, optimize guideline-directed heart-failure treatment and resynchronisation when indicated before considering transcatheter or surgical treatment. Acute severe regurgitation with shock or pulmonary oedema needs urgent stabilization, causal treatment and surgical evaluation. A Heart Team recommendation must account for local expertise, affordability, durability, anticoagulation, pregnancy and follow-up.
Prescribing Information
Prescribing treats consequences and associated disease; it does not substitute for correcting a severe mechanical lesion. Use diuretics for congestion with monitoring of blood pressure, renal function, electrolytes, weight and symptoms. In secondary regurgitation with heart failure, prescribe evidence-based heart-failure therapy according to ventricular phenotype, renal function, potassium, blood pressure and current local guidance. Atrial fibrillation requires individualized rate or rhythm management. Excessive bradycardia can worsen low output, while uncontrolled tachycardia can sharply worsen stenotic filling pressure.
Anticoagulant choice requires exact valve and rhythm classification. Current international valve guidance retains vitamin K antagonists for atrial fibrillation with significant mitral stenosis and for mechanical valves; direct oral anticoagulants should not be substituted casually in these groups. Verify indication, target and monitoring plan locally, review interactions and bleeding, and provide peri-procedural instructions. Pregnancy, severe anaemia, renal dysfunction and poor INR access need specialist planning rather than an undocumented dose change.
For prior rheumatic fever or established rheumatic heart disease, WHO recommends intramuscular benzathine benzylpenicillin as the preferred secondary-prophylaxis approach, with oral penicillin an alternative when intramuscular treatment is not suitable. Product, dose, interval and duration depend on age, history, valve disease and an applicable protocol; allergy assessment and adherence support are essential. Antibiotic prophylaxis against infective endocarditis is reserved for defined highest-risk cardiac conditions and relevant procedures, not all native mitral disease. Do not prescribe antibiotics for a murmur, or interrupt chronic prophylaxis, without confirming the indication. Fever before antibiotics should prompt cultures when endocarditis is possible.
When to Refer
Refer to cardiology when echocardiography shows more than mild disease, symptoms are disproportionate, the mechanism is unclear, atrial fibrillation develops, pulmonary pressure rises, ventricular size or function changes, pregnancy is planned, or surveillance cannot be delivered safely. A useful referral includes symptom trajectory, rhythm, examination, previous rheumatic fever and prophylaxis, anticoagulation, comorbidity, pregnancy status, dental or infection history and the complete echocardiographic report with images when transferable. Avoid sending only a label such as mitral stenosis without severity or morphology.
Refer to a Heart Valve Centre or experienced multidisciplinary service for severe disease, mixed or multivalve disease, uncertain severity, failed previous intervention, suspected prosthetic dysfunction, complex calcification or consideration of commissurotomy, repair, replacement or transcatheter treatment. Earlier discussion is appropriate before irreversible ventricular or pulmonary vascular damage. In rheumatic stenosis, intervention planning needs valve morphology, commissural fusion, regurgitation severity and exclusion of left-atrial thrombus. In regurgitation, mechanism and the probability of a durable repair are central.
Urgent same-day assessment is needed for acute pulmonary oedema, hypoxia, hypotension, syncope with instability, new neurological deficit, suspected systemic embolism, fever with valve disease, rapidly worsening dyspnoea or suspected acute severe regurgitation. Pregnancy with breathlessness at rest, pulmonary oedema, cyanosis or arrhythmia needs joint obstetric-cardiology evaluation. Indian pathways may require coordination between district services, medical colleges and tertiary cardiac centres. Confirm destination, financing, transport, record transfer and follow-up; a nominal referral is unsafe if the patient cannot reach or re-enter care.
Red Flags
Shock, cool peripheries, altered mentation, oliguria, severe hypoxaemia or rapidly developing pulmonary oedema can signal acute severe regurgitation or advanced stenotic decompensation. A new murmur after myocardial infarction, abrupt breathlessness after infection, or flail leaflet from chordal rupture requires emergency echocardiography and surgical discussion. Murmur loudness must not provide false reassurance. New focal neurological deficit, limb ischaemia, severe abdominal pain or visual loss may represent embolism; emergency pathways precede routine valve follow-up.
Fever, rigors, persistent malaise, positive blood cultures, new conduction disturbance, changing regurgitation or peripheral embolic signs raise infective endocarditis. Obtain appropriate blood cultures before antimicrobials when the patient is stable, but do not delay sepsis treatment in shock. New chest pain, collapse or severe regurgitation may reflect peri-annular extension or another cardiovascular emergency. A mechanical-valve patient with sudden dyspnoea, muffled or altered prosthetic sounds, subtherapeutic anticoagulation or embolism needs urgent assessment for valve thrombosis or dysfunction.
Pregnancy reduces tolerance of significant stenosis because heart rate and circulating volume rise. Orthopnoea, resting tachycardia, pulmonary oedema, syncope or haemoptysis warrants urgent multidisciplinary care. Anticoagulant-associated major bleeding, head injury, melaena or sudden severe headache requires emergency evaluation; patients should not independently stop anticoagulation without real-time clinical advice. Progressive exercise intolerance, rising pulmonary pressure, new atrial fibrillation or ventricular deterioration are not dramatic emergencies but are time-sensitive warning signs that surveillance has become an intervention decision.
Indian Clinical Context
Rheumatic disease makes an India-facing mitral guide materially different from one written only for ageing degenerative populations. Prevention spans prompt assessment of suspected streptococcal infection, recognition of rheumatic fever, long-term secondary prophylaxis, adherence support and continuity across adolescence, pregnancy and migration. WHO links rheumatic fever and rheumatic heart disease with crowding, poverty, water and sanitation constraints, and barriers to care. These are clinical determinants rather than reasons to blame families for missed injections or late presentation.
Access is heterogeneous. A district hospital may provide auscultation, ECG, diuresis and referral but not expert echocardiography, transoesophageal imaging, commissurotomy or valve repair. Tertiary centres differ in repair volume, catheter capability, blood-bank support, cardiac surgery and long-term anticoagulation services. Treatment choice must therefore balance guideline-defined suitability with achievable quality. Choosing replacement solely because it is immediately available can create lifelong anticoagulation, pregnancy and monitoring burdens; delaying a necessary operation while seeking an unavailable repair can also cause harm. Transparent shared decisions should include durability, reintervention, travel and cost.
Rheumatic secondary prophylaxis may fail because of stock interruptions, pain, allergy labels, distance or fragmented records. Establish the actual preparation and schedule, maintain a portable register and investigate true hypersensitivity rather than silently abandoning prophylaxis. INR monitoring, pregnancy counselling, dental care and infective-endocarditis education require the same continuity. International ESC and AHA recommendations inform principles but are not Indian service mandates. Apply Indian formularies, programme availability and institutional protocols, document where evidence is extrapolated, and avoid presenting specialist transcatheter technology as universally accessible or superior.
NMC Competency Mapping
The NMC CBME 2024 curriculum supports integration across physiology, pathology, microbiology, pharmacology and medicine. PY5 competencies establish cardiac cycle, haemodynamics, heart sounds, ECG and cardiovascular examination. PA26.5 addresses the aetiology, pathophysiology, morphology, criteria and complications of rheumatic fever. GM1.1 covers common rheumatic and valvular causes of heart disease; GM1.2 covers rheumatic fever, rheumatic valvular disease, penicillin prophylaxis and infective-endocarditis complications; and GM1.18 requires severity assessment using clinical, laboratory and imaging features. Microbiology learning links streptococcal disease and infective endocarditis to organism identification and laboratory diagnosis.
For mitral stenosis, a learner should explain commissural fusion, the diastolic pressure gradient, left-atrial enlargement, atrial fibrillation, pulmonary hypertension and right-heart consequences. They should connect the opening snap and mid-diastolic murmur with haemodynamics while recognising that echocardiography, not auscultation alone, grades severity. For regurgitation, they should distinguish primary leaflet pathology from ventricular and atrial secondary mechanisms, describe volume overload and understand why acute regurgitation may cause shock without a dilated chamber.
Applied competence includes taking a rheumatic and prophylaxis history, identifying decompensation, reading ECG and chest radiograph contextually, requesting transthoracic echocardiography and making a safe referral. Learners should describe the principles of commissurotomy, repair and replacement without selecting a procedure independently. Anticoagulation, penicillin prophylaxis, pregnancy and endocarditis prevention require patient-specific supervised prescribing. Reading this guide does not certify echocardiographic quantification, transoesophageal imaging, catheter intervention, valve surgery or anticoagulation management.
Key Exam Pearls for NEET PG
Rheumatic mitral stenosis classically produces commissural fusion, leaflet thickening and subvalvular involvement. The opening snap follows the second heart sound; a shorter A2-to-opening-snap interval generally reflects higher left-atrial pressure when the valve remains mobile. The apical low-pitched mid-diastolic rumble is accentuated before systole only in sinus rhythm. Atrial fibrillation removes presystolic accentuation and raises embolic risk. Pulmonary hypertension can produce a loud pulmonary component of the second sound and right-heart findings. Clinically severe rheumatic stenosis is commonly framed around a mitral valve area of 1.5 square centimetres or less, but intervention also depends on symptoms, anatomy and consequences.
Mitral regurgitation causes systolic volume flow into the left atrium. Chronic primary regurgitation allows left-atrial and left-ventricular adaptation; acute papillary-muscle or chordal failure does not, so pulmonary oedema may be profound despite limited chamber enlargement and a less impressive murmur. Primary regurgitation is intrinsic valve disease. Secondary regurgitation reflects ventricular or atrial remodelling; treating heart failure and resynchronisation when indicated comes before valve intervention in ventricular secondary disease.
Percutaneous commissurotomy suits selected rheumatic stenosis with favourable morphology and without important contraindications such as left-atrial thrombus or more than mild regurgitation. Durable surgical repair is preferred over replacement for repairable severe primary regurgitation. Mechanical prostheses require vitamin K antagonist anticoagulation; significant mitral stenosis with atrial fibrillation also remains a vitamin K antagonist setting in current valve guidance. Native rheumatic mitral disease alone is not an automatic indication for dental antibiotic prophylaxis. Never confuse rheumatic secondary prophylaxis, which prevents recurrent rheumatic fever, with procedure-related infective-endocarditis prophylaxis.
Frequently Asked Questions
Can medicines cure severe mitral stenosis or mitral regurgitation?
No medicine can open a fused rheumatic valve or restore a ruptured chord. Diuretics, rate or rhythm control, heart-failure therapy and anticoagulation can relieve symptoms or prevent complications. Severe mechanical disease may still require commissurotomy, repair, replacement or a selected transcatheter procedure after specialist assessment.
Does every person with mitral valve disease need antibiotics before dental treatment?
No. Procedure-related infective-endocarditis prophylaxis is limited to defined highest-risk cardiac conditions and qualifying procedures; native mitral stenosis or regurgitation alone is not automatically included. Good oral health remains important. The clinician and dentist should verify the current applicable protocol and exact valve history.
Why is pregnancy planning important in mitral stenosis?
Pregnancy increases circulating volume and heart rate, shortening diastolic filling and potentially raising left-atrial and pulmonary pressures. Significant stenosis may therefore decompensate even when daily activity was previously tolerated. Pre-pregnancy valve, rhythm, anticoagulation and intervention assessment enables safer shared planning with cardiology and obstetric teams.
Is a mechanical valve always the most durable and therefore the best choice?
Mechanical valves are durable but require lifelong vitamin K antagonist anticoagulation and reliable monitoring, with major implications for bleeding, pregnancy and access. Bioprosthetic valves and repair have different durability and reintervention profiles. Choice is individualized through a Heart Team discussion of anatomy, age, goals and follow-up feasibility.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic